With this authorization, Medican is now advanced closer to export and bring the first product to market. Medican now holds both a cannabis bulk with cultivation performed under GACP and a EU GMP manufacturing license.
More information about the authorization to produce cannabis intermediate products can be found here: https://laegemiddelstyrelsen.dk/en/special/medicinal-cannabis/companies/pilot-programme/Fremstillertilladelser/authorisation-to-produce-cannabis-intermediate-products/